Navigation Links
John Theurer Cancer Center and Leukemia & Lymphoma Society Highlight Upcoming Trends in Hematological Malignancies
Date:9/21/2009

HACKENSACK, N.J., Sept. 21 /PRNewswire/ -- The John Theurer Cancer Center at Hackensack University Medical Center, the nation's fourth largest cancer center, and the Leukemia & Lymphoma Society have joined forces to host the Hematological Malignancies Conference on Saturday, September 26, 2009 in Hackensack, NJ. The conference is free and attendees can receive continuing medical education (CME) credits.

Hematological malignancies are the types of cancer that affect blood, bone marrow, and lymph nodes.

Oncology experts from leading cancer organizations from around the country, including the John Theurer Cancer Center, MD Anderson Cancer Center, the Mayo Clinic, Dana Farber Cancer Institute and the National Cancer Institute, will discuss trends in patient care, novel therapies through clinical trials and emerging concepts in the management of hematological malignancies. Key topics include chronic lymphocytic leukemia, the role of molecular biomarkers in diffuse large b-cell lymphoma, follicular lymphoma, management of multiple myeloma and immunomodulation and hematopoietic stem cell transplant.

Featured Speakers:

  • Andre Goy, M.D. - Deputy Director, John Theurer Cancer Center, Chief, Division of Lymphoma; Director, Cancer Research
  • Susan O'Brien, M.D. - MD Anderson Cancer Center; Professor, Department of Leukemia, Division of Cancer Medicine
  • Wyndham Wilson, M.D., Ph.D. - National Cancer Institute, Chief, Lymphoma Therapeutics, Metabolic Branch, Center for Cancer Research
  • Carol Portlock, M.D. - Memorial Sloane-Kettering Cancer Center, Professor of Medicine, Attending Physician of Lymphoma
  • Rafael Fonseca, M.D. - Mayo Clinic, Professor of Medicine, Deputy Director of Mayo Clinic Cancer Center
  • Robert J. Soiffer, M.D. - Dana Farber Cancer Institute, Harvard Medical Professor of Medicine, Harvard Medical School, Chief Division of Blood Centers

This conference is open to the public, but directed primarily for medical oncologists and hematologists, as well as other healthcare professionals in the oncology field who are interested in the treatment of cancer. The conference will be held from 8 am to 2:30 pm in the Hekemian Conference Center Auditorium located at Hackensack University Medical Center, 30 Prospect Ave., Hackensack, New Jersey. If you're interested in attending please contact David Marisol at 201-996-2515 or marisoldavid@humed.com.

John Theurer Cancer Center at Hackensack University Medical Center

The John Theurer Cancer Center at Hackensack University Medical Center is New Jersey's largest and most comprehensive center dedicated to the diagnosis, treatment, management, research, screenings, and preventive care as well as survivorship of patients with all types of cancer. The 15 specialized divisions covering the complete spectrum of cancer care have developed a close-knit team of medical, research, nursing, and support staff with specialized expertise that translates into more advanced, focused care for all patients. Each year, more people in the New Jersey/New York metropolitan area turn to the John Theurer Cancer Center for cancer care than to any other facility in New Jersey. Housed within a 775-bed, not-for-profit teaching, tertiary care, and research hospital, the John Theurer Cancer Center provides state-of-the-art technological advances, compassionate care, research innovations, medical expertise, and a full range of after care services that distinguish the John Theurer Cancer Center from other facilities.


'/>"/>
SOURCE The John Theurer Cancer Center at Hackensack University Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. News from Medialink and P&G: Procter & Gamble Partners with National Breast Cancer Foundation, Inc. to GIVE HOPE to Millions of Women Across the Country
2. Study Published in The Lancet Showed Significant Survival Benefit for Patients Facing Deadly Form of Lung Cancer
3. Surgeon Battling Own Cancer Developed New Treatment
4. New Chemo Regimen May Benefit Ovarian Cancer Patients
5. New Drug May Offer Hope to Some With Lung Cancer
6. Hormone Therapy May Make Lung Cancer More Likely
7. Mens Health Network, The Washington Redskins and GlaxoSmithKline Team Up for Septembers Prostate Cancer Awareness Month
8. Guatemala Treatment Center Becomes First in Latin America to Introduce Fast and Precise RapidArc Radiotherapy Cancer Treatments
9. Henry Ford Hospital Offers Free Prostate Cancer Screenings
10. Scientists May Know How Lung Cancer Spreads
11. The Lustgarten Foundation Expresses Condolences as Pancreatic Cancer Claims Life of Myles Brand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true meaning of ... three in Oklahoma City, and a devoted woman of faith. , “Becoming a parent ... the back of my mind for years, but actually doing it might have been a ...
(Date:1/19/2017)... (PRWEB) , ... January 20, 2017 , ... Today, the ... to participate in four of CMS’s Alternative Payment Models (APMs) in 2017. Clinicians who ... patients. APMs are an important part of the Administration’s effort to build a ...
(Date:1/19/2017)... ... , ... With the cold weather here, many people will have to clear snow with snow ... amounts of snow, but they can be dangerous when used incorrectly. That’s why Amica ... the proper use of snow blowers:, , When removing wet snow ...
(Date:1/19/2017)... Melville, New York (PRWEB) , ... January 19, ... ... state–of-the-art high definition dynamic telemedicine solutions, has recently unveiled impressive transportable capabilities with ... this newly designed product is an extension to RMT technology that delivers HD, ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... the American Board of Dermatology and fellowship trained Mohs and cosmetic surgeon. After ... of Health, Dr. Li completed his internship in internal medicine at the Emory ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... , Jan. 18, 2017  EnteroMedics Inc. (NASDAQ: ... devices using neuroblocking technology to treat obesity, metabolic ... pricing of an underwritten public offering of units ... deducting underwriting discounts and commissions and offering expenses ... comprised of Class A Units, priced at a ...
(Date:1/18/2017)... PUNE, India , January 18, 2017 /PRNewswire/ ... Research, titled, "Breast Imaging Technologies Market by Type: Global Opportunity ... imaging technologies market size was valued at $2,544 million in ... growing at a CAGR of 8.4% from 2016 to 2022. ... together accounted for over three-fourths market share in ...
(Date:1/18/2017)... The Philadelphia Pediatric Medical Device Consortium (PPDC) has announced seed ... Consortium chose those companies from eight finalists in ... The devices under development are a powered orthotic arm ... delivery system for emergency situations and a device that gradually ... ...
Breaking Medicine Technology: